Depo-Provera: new concerns--same issues?
Robinson
Kris
K
St. Boniface General Hospital, Winnipeg, Manibota, Canada.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D015519:Bone Density / Q000187:drug effects; D002170:Canada; D002986:Clinical Trials as Topic; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D004348:Drug Labeling; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000139:chemically induced*; D007258:Informed Consent; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects*; D010024:Osteoporosis / Q000139:chemically induced*; D010353:Patient Education as Topic; D018579:Patient Selection; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration; D016387:Women's Health
D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate